HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6-bromoconduritol

Also Known As:

bromoconduritol; 4-Cyclohexene-1,2,3-triol, 6-bromo-

Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclohexanes: 3
        Cyclohexenes: 4
        6-bromoconduritol: 4
- Alcohols: 595
  - Sugar Alcohols: 143
    - Inositol: 2982
      - 6-bromoconduritol: 4
Carbohydrates: 22023
- Sugar Alcohols: 143
  - Inositol: 2982
    - 6-bromoconduritol: 4

Experts

1.	Cressey, Ratchada: 1 article (12/2017)
2.	Inboot, Nichanan: 1 article (12/2017)
3.	Khaodee, Worapong: 1 article (12/2017)
4.	Kumsaiyai, Warunee: 1 article (12/2017)
5.	Udomsom, Suruk: 1 article (12/2017)

Related Diseases

1.	Neoplasms (Cancer) 12/01/2017 - "Since blocking autophagy by lysosomal inhibitors enhanced the apoptosis-inducing effect of bromoconduritol, independent of p53 status, their combined use may hold promise for the treatment of cancer, particularly lung cancer." 01/01/1988 - "Thus, the potential of murine sarcoma L-1 cells to form experimental lung metastases after i.v. injection was assessed after inhibiting tumor cell protein glycosylation with tunicamycin, swainsonine, bromoconduritol, or 1-desoxynojirimycin. " 01/01/1988 - "Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice."
2.	Lung Neoplasms (Lung Cancer) 12/01/2017 - "Since blocking autophagy by lysosomal inhibitors enhanced the apoptosis-inducing effect of bromoconduritol, independent of p53 status, their combined use may hold promise for the treatment of cancer, particularly lung cancer."
3.	Sarcoma (Soft Tissue Sarcoma) 01/01/1988 - "Thus, the potential of murine sarcoma L-1 cells to form experimental lung metastases after i.v. injection was assessed after inhibiting tumor cell protein glycosylation with tunicamycin, swainsonine, bromoconduritol, or 1-desoxynojirimycin. " 01/01/1988 - "Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice."
4.	Neoplasm Metastasis (Metastasis) 01/01/1988 - "Thus, the potential of murine sarcoma L-1 cells to form experimental lung metastases after i.v. injection was assessed after inhibiting tumor cell protein glycosylation with tunicamycin, swainsonine, bromoconduritol, or 1-desoxynojirimycin. "
5.	Infections 04/01/1989 - "We have found that fresh human serum enhances the infectivity of HIV-1 in MT-2 cell infection assays when virus is synthesized in the presence of the mannosidase I inhibitor, 1-deoxymannojirimycin, or the mannosidase II inhibitor, swainsonine, but has no enhancing effect on virus synthesized in the presence of the glucosidase I inhibitors, castanospermine and 1-deoxynojirimycin, or the glucosidase II inhibitor, bromoconduritol. "

Related Drugs and Biologics

1.	Swainsonine
2.	Glycoproteins (Glycoprotein)
3.	4-nitrophenyl-alpha-glucosidase
4.	Small Interfering RNA (siRNA)
5.	1-Deoxynojirimycin (1 Deoxynojirimycin)
6.	Tunicamycin
7.	Enzymes
8.	mannosyl-oligosaccharide 1,2-alpha-mannosidase
9.	glucosidase I
10.	mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidase

Related Therapies and Procedures

1.	Treatment Delay